The global API market is expected to grow at healthy CAGR of 8% for the next five years and innovation is the only way forward. However, the traditional approach for testing at R&D laboratories today is proving to be a huge deterrent for innovation. Scientists are faced with extremely long waiting times, and hence, play safe by trying out fewer ideas. This leaves out many possible opportunities that could have resulted in millions of dollars.
With the combined expertise of design and technology and its industry experience, ACG Pharma Technologies offers a wide range of R&D scale fluid bed processors.